Decreasing statin copayments because of the patent expiration of simvastatin has led to moderate increases in therapy adherence.
Emily R. Cox, PhD
Advertisement
Articles by Emily R. Cox, PhD
Advertisement
Latest Updated Articles
- Prescribing COX-2s for Patients New to Cyclo-oxygenase Inhibition Therapy
Published: November 1st 2003 | Updated:
- Relationship Between Generic and Preferred-brand Prescription Copayment Differentials and Generic Fill Rate
Published: June 1st 2007 | Updated:
- Plan-Sponsor Savings and Member Experience With Point-of-Service Prescription Step Therapy
Published: July 1st 2004 | Updated:
- Lowering Copayments: Impact of Simvastatin Patent Expiration on Patient Adherence
Published: December 1st 2008 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review
2
US, Japan Patients With Diabetes Discontinue Semaglutide After First Year
3
How Clinician-Led Partnerships Strengthen Post-Acute Care
4
Contributor: Medication Adherence as a Journey—A Year-Round Strategy for Medicare Advantage Success
5
